Skip to main content
Equibles

Jones Hill Capital LP

Position in GPCR — Structure Therapeutics Inc.

CIK 2102314 NEW YORK, NY
Back to GPCR Full portfolio

Position in GPCR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,177,230
-$2,671,352 QoQ
Shares Held
40,567
-59.7% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#87
of 190 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Jones Hill Capital LP holds $379,449,729 across 26 Biotechnology names. GPCR ranks #23 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BMRN
Biomarin Pharmaceutical Inc
 1,431,590 $81,915,579
2 ARQT
Arcutis Biotherapeutics, Inc.
 1,089,701 $28,571,960
3 MDGL
Madrigal Pharmaceuticals, Inc.
 52,545 $28,214,037
4 BCAX
Bicara Therapeutics Inc.
 892,621 $26,501,917
5 RLMD
Relmada Therapeutics, Inc.
 3,655,075 $25,293,119
6 TRVI
Trevi Therapeutics, Inc.
 1,339,212 $24,976,303
7 PHVS
Pharvaris N.V.
 677,879 $23,441,055
8 XENE
Xenon Pharmaceuticals Inc.
 367,900 $22,206,444

All Filings in GPCR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,177,230 40,567
2026-03-31 $4,848,582 100,593